Exploring your options for Pediatric Leukemia in India? Ginger Healthcare brings together a carefully chosen panel of reputed hematologists, practising at world-class hospitals accredited by JCI and NABH. Request a free opinion and a cost estimate from any doctor on the list, and our team will guide you through every step of your journey.
Here are the most reputed doctors in India for Pediatric Leukemia Treatment. Each specialist is carefully vetted for their expertise, experience, and patient outcomes.
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Here are the most reputed hospitals in India for Pediatric Leukemia Treatment. These hospitals are known for advanced infrastructure, international accreditations, and high success rates.
Pediatric leukemia is a cancer of the blood-forming tissue in the bone marrow, where abnormal immature white blood cells — called blasts — multiply uncontrollably and crowd out healthy red cells, white cells, and platelets. It is the most common childhood cancer, and modern medicine has made remarkable progress in treating it: childhood acute lymphoblastic leukemia (ALL), the most frequent type, now has cure rates above 85–90% in well-resourced centers. Treatment is tailored to the specific leukemia type (ALL, AML, CML, or rarer subtypes), the child's risk category, and how the disease responds to early therapy. The main treatment approaches include multi-drug chemotherapy protocols delivered in phases, targeted or immune-based therapies for specific molecular subtypes, and hematopoietic stem cell transplant (bone marrow transplant) for high-risk or relapsed disease. Treatment typically spans two to three years for ALL, or six to nine months of intensive chemotherapy for AML.
Multi-phase chemotherapy delivered over two to three years for acute lymphoblastic leukemia — the most frequent childhood leukemia — beginning with intensive induction and progressing to gentler home-based maintenance.
Estimated cost: ~$1,000 – $2,500
Typical tests: Complete blood count (CBC) with differential and reticulocyte count, Bone marrow aspiration and biopsy with immunophenotyping (flow cytometry), Cytogenetics — karyotype, FISH panel for key translocations, Molecular testing — PCR for BCR-ABL, TEL-AML1, MLL rearrangements, MRD baseline, Lumbar puncture with CSF cytology, 2D Echocardiogram (baseline cardiac function before anthracyclines), Renal and liver function tests, uric acid, LDH, electrolytes, Chest X-ray and ultrasound abdomen/pelvis, Pediatric anesthesia clearance assessment. Done in India before admission.
Estimated cost in India: $6,000 – $15,000
Treatment duration in India: ~6 weeks (~35 hospital visit days across the full span)
Shorter but more intensive chemotherapy delivered over approximately six to nine months in repeated inpatient cycles for acute myeloid leukemia, which requires more aggressive treatment than ALL.
Estimated cost: ~$1,500 – $2,500
Typical tests: Complete blood count (CBC) with differential and reticulocyte count, Bone marrow aspiration and biopsy with immunophenotyping (flow cytometry), Cytogenetics — karyotype and FISH for AML-relevant translocations (t(8;21), inv(16), t(15;17)), Molecular testing — FLT3-ITD, NPM1, CEBPA, KIT, IDH1/2 mutations; PML-RARA for APL, Lumbar puncture with CSF cytology, 2D Echocardiogram and ECG (anthracycline baseline), Renal and liver function tests, uric acid, LDH, coagulation profile (PT/INR/APTT), HLA typing (for potential transplant planning), Pediatric anesthesia clearance assessment. Done in India before admission.
Estimated cost in India: $10,000 – $20,000
That works out to roughly $2,000 – $4,500 per cycle across 4 cycles, plus a one-time pre-treatment work-up of about ~$1,500 – $2,500 (done once). Per-cycle figures are approximate — the headline range above covers the full course.
Treatment duration in India: ~6 months (4 cycles × 28 days, ~112 hospital visit days)
Daily oral tyrosine kinase inhibitor (TKI) medication combined with standard chemotherapy, used for children whose leukemia carries the Philadelphia chromosome — a genetic change that makes standard chemotherapy alone less effective.
Estimated cost: ~$1,500 – $2,500
Typical tests: Complete blood count (CBC) with differential, Bone marrow aspiration and biopsy with immunophenotyping, Cytogenetics — Philadelphia chromosome (t(9;22)) confirmation by karyotype and FISH, Quantitative BCR-ABL PCR (p190 for ALL, p210 for CML) — baseline, ABL kinase domain mutation screening (if prior TKI exposure), Lumbar puncture with CSF cytology (for Ph+ ALL), 2D Echocardiogram and ECG, Renal and liver function tests (TKI hepatotoxicity monitoring baseline), Pediatric anesthesia clearance assessment. Done in India before admission.
Estimated cost in India: $8,000 – $18,000
Treatment duration in India: ~6 weeks (~30 hospital visit days across the full span)
Replacement of the child's diseased bone marrow with healthy donor stem cells — recommended for high-risk leukemia subtypes, disease that has not responded adequately to chemotherapy, or leukemia that has relapsed.
Estimated cost in India: $20,000 – $45,000
For more details, visit: Pediatric Bone Marrow Transplant →
A cutting-edge immunotherapy where the child's own T-cells are genetically engineered in a laboratory to recognise and destroy leukemia cells, used when B-cell ALL has come back or has not responded to prior treatments.
Estimated cost in India: $35,000 – $60,000
For more details, visit: CAR-T Cell Therapy →
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.
